Continuing Access to In-Home IVIG Act

I 116TH CONGRESS 2D SESSION H. R. 7839 To amend the Medicare IVIG Access and Strengthening Medicare and Repay- ing Taxpayers Act of 2012 to extend the Medicare Patient IVIG Access Demonstration Project. IN THE HOUSE OF REPRESENTATIVES JULY 29, 2020 Ms. MATSUI (for herself and Mr. BRADY) introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provi- sions as fall within the jurisdiction of the committee concerned A BILL To amend the Medicare IVIG Access and Strengthening Medicare and Repaying Taxpayers Act of 2012 to extend the Medicare Patient IVIG Access Demonstration Project. Be it enacted by the Senate and House of Representa- 1 tives of the United States of America in Congress assembled, 2 SECTION 1. SHORT TITLE. 3 This Act may be cited as the ‘‘Continuing Access to 4 In-Home IVIG Act’’. 5 VerDate Sep 11 2014 23:27 Aug 17, 2020 Jkt 099200 PO 00000 Frm 00001 Fmt 6652 Sfmt 6201 E:\BILLS\H7839.IH H7839 kjohnson on DSK79L0C42PROD with BILLS 2 •HR 7839 IH SEC. 2. EXTENSION OF MEDICARE PATIENT IVIG ACCESS 1 DEMONSTRATION PROJECT. 2 (a) EXTENSION OF DEMONSTRATION PROJECT.— 3 Section 101(b) of the Medicare IVIG Access and Strength- 4 ening Medicare and Repaying Taxpayers Act of 2012 (42 5 U.S.C. 13951 note) is amended— 6 (1) by striking paragraph (1) and inserting the 7 following: 8 ‘‘(1) DURATION.—Beginning not later than one 9 year after the date of enactment of this Act, the 10 Secretary shall conduct the demonstration project 11 for a period of 3 years and, subject to the avail- 12 ability of funds under subsection (g), the period be- 13 ginning on October 1, 2017, and ending on Decem- 14 ber 31, 2022.’’; and 15 (2) in paragraph (2)— 16 (A) by striking ‘‘4,000’’ and inserting 17 ‘‘6,500’’; and 18 (B) by striking ‘‘2020’’ and inserting 19 ‘‘2022’’. 20 (b) UPDATED EVALUATION AND REPORT.—Section 21 101(f) is amended— 22 (1) by redesignating paragraph (2) as para- 23 graph (3); and 24 (2) by inserting after paragraph (1) the fol- 25 lowing new paragraph: 26 VerDate Sep 11 2014 23:27 Aug 17, 2020 Jkt 099200 PO 00000 Frm 00002 Fmt 6652 Sfmt 6201 E:\BILLS\H7839.IH H7839 kjohnson on DSK79L0C42PROD with BILLS 3 •HR 7839 IH ‘‘(2) UPDATED EVALUATION AND REPORT.— 1 Not later than one year after the date of the enact- 2 ment of the Continuing Access to In-Home IVIG 3 Act, the Secretary shall submit to Congress an up- 4 dated report that contains the following: 5 ‘‘(A) The total number of beneficiaries en- 6 rolled in the demonstration project during the 7 updated report period. 8 ‘‘(B) The total number of claims submitted 9 for services during the updated report period, 10 disaggregated by month. 11 ‘‘(C) An analysis of the impact of the dem- 12 onstration on beneficiary access to the in-home 13 administration of intravenous immune globin, 14 including the impact on beneficiary health and 15 well-being. 16 ‘‘(D) An analysis of the impact of in-home 17 administration of intravenous immune globin on 18 overall costs to Medicare, including the cost dif- 19 ferential between in-home administration of in- 20 travenous immune globin and administration of 21 intravenous immune globin in a healthcare fa- 22 cility. 23 ‘‘(E) A survey of providers and enrolled 24 beneficiaries that participated in the demonstra- 25 VerDate Sep 11 2014 23:27 Aug 17, 2020 Jkt 099200 PO 00000 Frm 00003 Fmt 6652 Sfmt 6201 E:\BILLS\H7839.IH H7839 kjohnson on DSK79L0C42PROD with BILLS 4 •HR 7839 IH tion project that identifies barriers to accessing 1 services, including reimbursement for items and 2 services. 3 ‘‘(F) Recommendations to Congress on the 4 appropriateness of establishing a permanent 5 bundled services payment for the in-home ad- 6 ministration of intravenous immune globin for 7 Medicare beneficiaries.’’. 8 (c) DEFINITION OF UPDATED REPORT PERIOD.— 9 Section 101(h) is amended by adding at the end the fol- 10 lowing new paragraph: 11 ‘‘(4) UPDATED REPORT PERIOD.—The term 12 ‘updated report period’ means the period beginning 13 on October 1, 2014, and ending on September 30, 14 2020.’’. 15 Æ VerDate Sep 11 2014 23:27 Aug 17, 2020 Jkt 099200 PO 00000 Frm 00004 Fmt 6652 Sfmt 6301 E:\BILLS\H7839.IH H7839 kjohnson on DSK79L0C42PROD with BILLS